[go: up one dir, main page]

DE69740161D1 - Nateglinide-Tablettenzubereitungen - Google Patents

Nateglinide-Tablettenzubereitungen

Info

Publication number
DE69740161D1
DE69740161D1 DE69740161T DE69740161T DE69740161D1 DE 69740161 D1 DE69740161 D1 DE 69740161D1 DE 69740161 T DE69740161 T DE 69740161T DE 69740161 T DE69740161 T DE 69740161T DE 69740161 D1 DE69740161 D1 DE 69740161D1
Authority
DE
Germany
Prior art keywords
meals
carboxymethyl cellulose
tablet composition
nateglinide tablets
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69740161T
Other languages
English (en)
Inventor
Akira Yabuki
Masato Kaida
Takahiko Ando
Nobutaka Ninomiya
Masanao Ozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69740161(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE69740161D1 publication Critical patent/DE69740161D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69740161T 1996-11-15 1997-11-14 Nateglinide-Tablettenzubereitungen Expired - Lifetime DE69740161D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15

Publications (1)

Publication Number Publication Date
DE69740161D1 true DE69740161D1 (de) 2011-05-12

Family

ID=18100283

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69735644T Expired - Lifetime DE69735644T2 (de) 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform
DE69740161T Expired - Lifetime DE69740161D1 (de) 1996-11-15 1997-11-14 Nateglinide-Tablettenzubereitungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69735644T Expired - Lifetime DE69735644T2 (de) 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform

Country Status (14)

Country Link
US (4) US6143323A (de)
EP (3) EP0965339B1 (de)
JP (1) JP4171091B2 (de)
KR (1) KR100343062B1 (de)
CN (1) CN1245158C (de)
AT (2) ATE503472T1 (de)
AU (1) AU718350B2 (de)
CA (1) CA2271865C (de)
DE (2) DE69735644T2 (de)
DK (1) DK1586314T3 (de)
ES (2) ES2257772T3 (de)
PT (2) PT965339E (de)
TW (1) TW492878B (de)
WO (1) WO1998022105A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE503472T1 (de) * 1996-11-15 2011-04-15 Ajinomoto Kk Nateglinide-tablettenzubereitungen
ES2559766T3 (es) 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
WO2000006126A1 (en) * 1998-07-28 2000-02-10 Takeda Chemical Industries, Ltd. Rapidly disintegrable solid preparation
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
CA2395993A1 (en) 1999-12-28 2001-07-05 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1234414C (zh) * 2000-03-17 2006-01-04 味之素株式会社 糖尿病性合并症和神经障碍用的药剂及其应用
DK1334962T3 (da) * 2000-10-18 2007-12-10 Ajinomoto Kk Fremgangsmåder til fremstilling af acylphenylalanin
RU2273629C2 (ru) * 2000-10-18 2006-04-10 Адзиномото Ко., Инк. Способы получения кристаллов натеглинида
BR0114846A (pt) 2000-10-24 2004-02-25 Ajinomoto Kk Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h
BR0114896A (pt) * 2000-10-24 2003-08-12 Ajinomoto Kk Preparação contendo nateglinida, e, método para produzir a mesma
AU2001296000A1 (en) * 2000-10-24 2002-05-27 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic drug preparations
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
JP4505859B2 (ja) * 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
KR20120064735A (ko) * 2004-04-01 2012-06-19 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
CA2575484A1 (en) * 2004-08-04 2006-02-16 Alza Corporation Sustained drug release composition demonstrating an ascending zero order release pattern, methods of manufacturing such a composition
EP1795207A1 (de) * 2004-10-01 2007-06-13 Nippon Zoki Pharmaceutical Co. Ltd. Feste pharmazeutische zubereitung
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
WO2006080524A1 (ja) * 2005-01-31 2006-08-03 Ajinomoto Co., Inc. 血糖降下剤を含有する、耐糖能異常、境界型糖尿病、インスリン抵抗性及び高インスリン血症の改善ないし治療用医薬組成物
KR101506043B1 (ko) * 2006-12-07 2015-03-25 다이이찌 산쿄 가부시키가이샤 저치환도 히드록시프로필셀룰로오스를 함유하는 의약 조성물
CA2672154C (en) * 2006-12-07 2014-11-18 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved storage stability
JP5289975B2 (ja) * 2006-12-07 2013-09-11 第一三共株式会社 マンニトール又は乳糖を含有する固形製剤
CA2672157C (en) * 2006-12-07 2016-07-26 Daiichi Sankyo Company, Limited Method for producing solid preparation
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
ATE149483T1 (de) 1991-07-30 1997-03-15 Ajinomoto Kk Kristalle von n-(trans-4- isopropylcyclohexylcarbonyl)-d-phenylalanin und verfahren zu ihrer herstellung
CA2123677A1 (en) * 1991-11-26 1993-06-10 Issac Ghebre-Sellassie Process and composition for the development of controlled release gemfibrozil dosage form
ATE503472T1 (de) * 1996-11-15 2011-04-15 Ajinomoto Kk Nateglinide-tablettenzubereitungen

Also Published As

Publication number Publication date
JP4171091B2 (ja) 2008-10-22
WO1998022105A1 (en) 1998-05-28
ES2257772T3 (es) 2006-08-01
US20020028239A1 (en) 2002-03-07
EP0965339A4 (de) 2003-04-23
PT965339E (pt) 2006-06-30
AU718350B2 (en) 2000-04-13
EP2277517A1 (de) 2011-01-26
ES2364145T3 (es) 2011-08-25
DE69735644T2 (de) 2007-05-03
KR100343062B1 (ko) 2002-07-02
US20030147951A1 (en) 2003-08-07
CA2271865A1 (en) 1998-05-28
CA2271865C (en) 2003-10-14
US6296872B1 (en) 2001-10-02
US6844008B2 (en) 2005-01-18
US6143323A (en) 2000-11-07
US6641841B2 (en) 2003-11-04
CN1242704A (zh) 2000-01-26
EP1586314A1 (de) 2005-10-19
KR20000053312A (ko) 2000-08-25
PT1586314E (pt) 2011-07-01
AU4965497A (en) 1998-06-10
EP0965339A1 (de) 1999-12-22
EP1586314B1 (de) 2011-03-30
EP0965339B1 (de) 2006-04-05
DE69735644D1 (de) 2006-05-18
ATE503472T1 (de) 2011-04-15
DK1586314T3 (da) 2011-06-20
JPH10194969A (ja) 1998-07-28
ATE322260T1 (de) 2006-04-15
TW492878B (en) 2002-07-01
CN1245158C (zh) 2006-03-15

Similar Documents

Publication Publication Date Title
DE69740161D1 (de) Nateglinide-Tablettenzubereitungen
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
ES2123903T3 (es) Composicion nutritiva conteniendo fibra.
DE69003392D1 (de) Dosisform zur oralen verabreichung des hypoglykämischen glipizids.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
ATE83651T1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
NO870772D0 (no) Vevplasminogenaktivator for normale humane tykktarmceller.
ATE73656T1 (de) Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist.
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
ATE204163T1 (de) Verkapselter arzneistoff
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
ID21038A (id) Tablet yang mengandung resin penukar anion
KR970706831A (ko) 당뇨병 치료용 약제 조성물(medicinal composition for diabetes)
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
DK162471C (da) Suge- eller tyggetablet
US6683098B1 (en) Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control
CN1109357A (zh) 一种美容保健制品及工艺方法
CA1179267A (en) Composition for relieving toothache pain
RU11467U1 (ru) Препарат "md"
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
SU1628281A3 (ru) Ранозаживляющее средство